Common RDCRN Acronyms
🔎 Quick Navigation
For a list of Consortium acronyms, visit:
For a list of Patient Advocacy Group acronyms, visit the RDCRN Website - PAGs
A
Acronym | Expansion | Notes / Context |
|---|---|---|
ADaM | Analysis Data Model | CDISC model for analysis datasets. |
AE | Adverse Event | Safety event captured on eCRFs per protocol. |
ALCOA+ | Attributable, Legible, Contemporaneous, Original, Accurate (+Complete, Consistent, Enduring, Available, Traceable) | Data integrity principles. |
B
Acronym | Expansion | Notes / Context |
|---|---|---|
BAA | Business Associate Agreement | HIPAA-required contract with a vendor/partner handling PHI; defines responsibilities for safeguarding, permitted uses, and breach notification. See also: DUA, DHA, DTA. |
C
Acronym | Expansion | Notes / Context |
|---|---|---|
CAPA | Corrective and Preventive Action | Quality process used to address protocol deviations/violations or audit findings; documents root cause, corrective steps, and preventive measures to avoid recurrence. |
CCHMC | Cincinnati Children’s Hospital Medical Center | Academic pediatric medical center; home of the DMCC and partner departments. |
CFR | Code of Federal Regulations | e.g., 21 CFR Part 11 (e-records), 45 CFR 46 (human subjects). |
CDASH | Clinical Data Acquisition Standards Harmonization | CDISC standard for designing CRFs/eCRFs and data-collection fields; aligns with SDTM. |
CDISC | Clinical Data Interchange Standards Consortium | SDTM, ADaM, Define-XML, etc. |
CPAG | Coalition of Patient Advocacy Groups | Patient advocacy arm of RDCRN; unites all consortium PAGs into a collaborative group where they are encouraged to co-develop and access tools helpful along their path toward clinical trial readiness. |
CRC | Clinical Research Coordinator | Coordinates day-to-day study conduct: visits, consent support, data entry, query resolution. |
CRF | Case Report Form | Structured data collection; “eCRF” in EDC (e.g., REDCap). Design via CDASH; trace to protocol endpoints. |
CRO | Contract Research Organization | External vendor for trial operations. |
CSV | Comma-separated values | File type for importing and exporting REDCap data |
D
Acronym | Expansion | Notes / Context |
|---|---|---|
DAG | Data Access Group: Who has access to view a record in REDCap, typically a clinical site or PI | REDCap feature isolating records by group/site; prevents cross-site viewing; membership assigned per user. |
DBE | Division of Biostatistics and Epidemiology at CCHMC | CCHMC group partnering on design, analysis, reporting, and methods support. |
DC | Data Coordinator | Supports the Data Manager (DM) by handling day-to-day operational tasks (e.g., data entry oversight, queries); ensures smooth execution under DM guidance. |
DCC | Data Coordinating Center | Synonym/near to DMCC depending on use. |
DHA | Data Hosting Agreement | Defines hosting responsibilities (platform, security, backups, uptime) when a vendor hosts study data; often paired with a BAA if PHI is involved. See also: BAA, DUA, DTA. |
DM | Data Manager | Leads the study’s data management activities; responsible for overall data quality, standards, and compliance. Provides oversight and direction to the Data Coordinator (DC). |
DMAC | Data Management & Analysis Collaborative | CCHMC internal group supporting DMCC. |
DMCC | Data Management & Coordinating Center | RDCRN central hub for data standards, quality, reporting, multi-site coordination, and RDCRN operations coordinating hub. |
DMP | Data Management Plan | Study-level plan for data processes. |
DQP | Data Quality Plan | Study-level plan outlining data quality expectations, edit checks, review procedures, and responsibilities; supports compliance and database lock readiness. |
DSMB | Data and Safety Monitoring Board | Independent committee that reviews accumulating study data for safety and efficacy; provides recommendations on continuation, modification, or termination of the trial. |
DTA/DTS | Data Transfer Agreement/Specifications | Governs secure transfer of study data between parties (format, cadence, encryption, contacts, responsibilities); may be paired with a BAA if PHI is transferred. See also: BAA, DUA, DHA. |
DUA | Data Use Agreement | Governs sharing of Limited Data Sets under HIPAA; legal contract defining permitted uses, disclosures, safeguards, and responsibilities. See also: LDS. |
E
Acronym | Expansion | Notes / Context |
|---|---|---|
EDC | Electronic Data Capture | Primary system for eCRFs. |
EDC | Engagement and Dissemination Core | Promotes patient engagement, network collaboration, and research dissemination |
eCOA | electronic Clinical Outcome Assessment | Includes ePRO, eDiary, etc. |
eCRF | electronic Case Report Form | Digital version of a CRF used within an Electronic Data Capture (EDC) system; ensures structured, validated data entry and traceability to protocol endpoints. See also: CRF. |
eICF | electronic Informed Consent Form | Digital implementation of the informed consent process; presented via electronic platforms with features like electronic signatures. See also: ICF. |
ePRO | electronic Patient-Reported Outcome | Participant-entered outcomes. |
eTMF | electronic Trial Master File | Digital repository of essential trial documents; demonstrates compliance with GCP and regulatory requirements; supports inspection readiness. |
F
Acronym | Expansion | Notes / Context |
|---|---|---|
FDA | U.S. Food and Drug Administration | Regulator for drugs/devices/biologics. |
FOA | Funding Opportunity Announcement | Older NIH/agency term for grant solicitations; replaced by “NOFO” but still used in legacy documents and references. |
FPFV | First Patient, First Visit | Study milestone. |
G
Acronym | Expansion | Notes / Context |
|---|---|---|
GCP | Good Clinical Practice | International ethical and scientific quality standard (ICH E6 (R3)) for designing, conducting, recording, and reporting trials; ensures rights, safety, and data integrity. |
GDPR | General Data Protection Regulation | EU data protection; de-identification, rights. |
GUID | Global Unique Identifier | De-identified participant code enabling cross-study linkage without sharing PII/PHI. |
H
Acronym | Expansion | Notes / Context |
|---|---|---|
HHS | U.S. Department of Health and Human Services |
|
HIPAA | Health Insurance Portability and Accountability Act | U.S. health data privacy. |
I
Acronym | Expansion | Notes / Context |
|---|---|---|
ICH | International Council for Harmonisation | International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use | Global standards-setting body; issues guidelines (e.g., E6 (R3) GCP, E3 CSR) harmonizing regulatory expectations across regions. |
ICF | Informed Consent Form | Document reviewed and signed by participants (or LARs) before study procedures; approved by IRB/ethics board and updated with protocol amendments. See also: eICF |
IRB | Institutional Review Board | Ethics oversight; approve protocol/consent before enrollment; monitor amendments and continuing review. |
IRT | Interactive Response Technology | Randomization/dispensing (a.k.a. IWRS/IVRS). |
IS4R | Information Services for Research | CCHMC internal group supporting DMCC. |
J
Acronym | Expansion | Notes / Context |
|---|---|---|
|
|
|
K
Acronym | Expansion | Notes / Context |
|---|---|---|
|
|
|
L
Acronym | Expansion | Notes / Context |
|---|---|---|
LAR | Legally Authorized Representative | Individual authorized under applicable law to consent on behalf of a participant (e.g., parent/guardian for a minor, proxy for an incapacitated adult). |
LDS | Limited Data Set | HIPAA-defined dataset with certain direct identifiers removed (e.g., name, address) but some dates and geographic info retained; requires a Data Use Agreement (DUA). See also: DUA. |
LPLV | Last Patient, Last Visit | Study milestone. |
M
Acronym | Expansion | Notes / Context |
|---|---|---|
MLP | Members Landing Page | The home page (https://members.rarediseasesnetwork.org/home/) for members of the RDCRN once they have authenticated and logged into their account through the public-facing RDCRN website (https://www.rarediseasesnetwork.org/ ) |
MOO | Manual of Operations | Program/network operations playbook—roles, workflows, communications; complements study-level MOP. |
MOP | Manual of Procedures | Study/site procedures manual—visit schedules, data collection, deviations, and query/lock workflows. |
N
Acronym | Expansion | Notes / Context |
|---|---|---|
NIH | National Institutes of Health | U.S. biomedical research agency (HHS); funds grants and sets research policy. |
NCATS | National Center for Advancing Translational Sciences | Steward of RDCRN; accelerates translation and supports rare-disease networks. |
NHLBI | National Heart, Lung, and Blood Institute | Heart, lung, and blood diseases; multi-center trials and data commons. |
NIAID | National Institute of Allergy and Infectious Diseases | Immunology/infectious disease research; clinical trials in vaccines and therapeutics. |
NIAMS | National Institute of Arthritis and Musculoskeletal and Skin Diseases | Arthritis, musculoskeletal, and skin research; supports networks/registries. |
NICHD | (Eunice Kennedy Shriver) National Institute of Child Health and Human Development | Child/maternal health, development, and reproduction; perinatology networks. |
NIDCR | National Institute of Dental and Craniofacial Research | Dental/craniofacial research; clinical studies and data standards in dentistry. |
NIDDK | National Institute of Diabetes and Digestive and Kidney Diseases | Diabetes, digestive, and kidney diseases; large cohorts and trials. |
NIMH | National Institute of Mental Health | Mental health research; clinical trials, outcome measures, and data sharing. |
NINDS | National Institute of Neurological Disorders and Stroke | Neurology and stroke research; funds natural-history and interventional studies. |
NOFO | Notice of Funding Opportunity | Current term for public grant solicitations (e.g., NIH); describes scope, eligibility, and application instructions; supersedes “FOA.” |
O
Acronym | Expansion | Notes / Context |
|---|---|---|
|
|
|
P
Acronym | Expansion | Notes / Context |
|---|---|---|
PA | Program Announcement | Broad NIH funding announcement used to encourage applications in a particular scientific area; typically reviewed in standard CSR study sections unless otherwise noted. |
PAG | Patient Advocacy Group | Patient-voice partners in design, outcomes, recruitment, and dissemination. |
PAR | Program Announcement Reviewed in an Institute | Type of NIH funding announcement; applications are reviewed by the sponsoring Institute/Center rather than CSR; often used for institute-specific initiatives. |
PD | Permissions Dashboard | The RDCRN Permissions Dashboard website displays RDCRN member accounts and their permissions within the RDCRN suite of tools, websites and services. |
PD
| Protocol Deviation | Departure from the approved protocol, procedures, or GCP requirements; may be classified as minor or major per SOP; must be documented and reviewed. See also: CAPA. |
PHI | Protected Health Information | Individually identifiable health information regulated by HIPAA; includes medical, demographic, and payment details linked to a person. Requires safeguards and often a BAA when shared with vendors. See also: PII. |
PI | Principal Investigator | Leads study at site/network. |